Longjournaal februari 2024

In dit Longjournaal

• Longschade bij Covidpatiënten¹
• Plasma verlaagt sterftecijfer²
• VUB leidt EU-project chronische longaandoeningen³
• Bronchiëctasie versus COPD⁴
• Extrafijn beclometason⁵

Referenties

1; https://www.uzgent.be/nieuws/eigen-afweer-veroorzaakt-longschade-bij-covid-patienten

2; Benoît Misset et al., Convalescent Plasma for Covid-19–Induced ARDS in Mechanically Ventilated Patients, N Engl J Med 2023; 389:1590-1600.

https://kce.fgov.be/nl/kce-trials/funded-trials/cov201004-een-multicenter-gerandomiseerde-studie-om-de-doeltreffendheid-te-beoordelen-van-een

https://www.news.uliege.be/cms/c_19009071/fr/le-plasma-de-convalescent-reduit-de-10-la-mortalite-des-patients-covid-19-en-detresse-respiratoire-aigue-et-sous-assistance-respiratoire-artificielle

3; https://www.vub.be/nl/nieuws/vub-aan-leiding-internationaal-consortium-palliatieve-zorg

4; Eva Polverino et al, The Association Between Bronchiectasis and Chronic Obstructive Pulmonary Disease: Data from the European Bronchiectasis Registry (EMBARC). Am J Respir Crit Care Med. 2024 Jan 25. Epub ahead of print.

https://www.atsjournals.org/doi/10.1164/rccm.202309-1614OC?url_ver=Z39.882003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed

5; Price D, et al. Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS. Pragmat Obs Res. 2024;15:1-16

 https://www.dovepress.com/risk-of-pneumonia-in-patients-with-copd-initiating-fixed-dose-inhaled--peer-reviewed-fulltext-article-POR